Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. uri icon

authors

  • Patel, Sapna P
  • Truong, Thach-Giao
  • Eisenstein, Jennifer L
  • Chandra, Sunandana
  • Sosman, Jeffrey A
  • Kendra, Kari L
  • Wu, Richard C
  • Devoe, Craig E
  • Deutsch, Gary B
  • Hegde, Aparna
  • Khalil, Maya
  • Othus, Megan
  • Mangla, Ankit
  • Reese, Amy M
  • Ross, Merrick I
  • Poklepovic, Andrew S
  • Phan, Giao Q
  • Onitilo, Adedayo A
  • Yasar, Demet G
  • Powers, Benjamin C
  • Doolittle, Gary C
  • In, Gino K
  • Chen, Yuanbin
  • Kokot, Niels
  • Gibney, Geoffrey T
  • Atkins, Michael B
  • Shaheen, Montaser
  • Warneke, James A
  • Ikeguchi, Alexandra
  • Najera, Jose E
  • Chmielowski, Bartosz
  • Crompton, Joseph G
  • Floyd, Justin D
  • Wright, G Paul
  • Hsueh, Eddy
  • Margolin, Kim A
  • Chow, Warren A
  • Grossmann, Kenneth F
  • Dietrich, Eliana
  • Prieto, Victor G
  • Lowe, Michael C
  • Buchbinder, Elizabeth I
  • Kirkwood, John M
  • Korde, Larissa
  • Yost, Kathleen J
  • Moon, James
  • Sharon, Elad
  • Sondak, Vernon K
  • Ribas, Antoni
  • Hyngstrom, John R
  • Hu-Lieskovan, Siwen
  • Lao, Christopher D
  • Fecher, Leslie A

publication date

  • January 1, 2023